NCT00519298View on ClinicalTrials.gov

Study Evaluating Effects of SAM-531 on Sleep Electroencephalogram (EEG) and Quantitative Wake EEG in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions

HealthyAdult

Interventions

DRUG

SAM-531

dosage form : 0.5 mg and 5 mg capsules 3 different single doses : 1 mg, 3mg and 10 mg of SAM-531

OTHER

placebo

DRUG

Donepezil

dosage form: 5 mg encapsulated tablets one single dose of 5 mg.

Trial Locations (1)

68250

Rouffach

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00519298 - Study Evaluating Effects of SAM-531 on Sleep Electroencephalogram (EEG) and Quantitative Wake EEG in Healthy Subjects | Biotech Hunter | Biotech Hunter